The price of Ubrelvy (ubrogepant) 100 mg can vary depending on factors such as insurance coverage, pharmacy, and location. While specific price lists are not publicly available, a 30-count prescription of Ubrelvy 100 mg may cost around $5,000 to $6,000 without insurance [1].
How much does Ubrelvy cost with insurance?
Insurance coverage for Ubrelvy significantly impacts the out-of-pocket cost for patients. Many insurance plans offer co-pay cards or savings programs that can reduce the cost. For instance, a Ubrelvy Savings Card can potentially lower the co-pay to as little as $0 for eligible commercially insured patients for a supply of up to 24 tablets [1]. However, this offer has limitations, such as a maximum savings of $1,300 per prescription and an annual maximum of $3,900 in savings [1]. Patients with Medicare, Medicaid, or other government-funded health plans are not eligible for this savings program [1].
Are there Ubrelvy coupons or discount programs?
Yes, patient assistance programs and discount cards are available for Ubrelvy. The manufacturer, AbbVie, offers a Ubrelvy Savings Card for commercially insured patients, which can reduce co-pays. For those who are uninsured or underinsured, AbbVie may offer other assistance programs, though eligibility criteria apply [1]. Online pharmacies and discount platforms may also offer savings, but these should be verified for legitimacy and coverage.
What is the difference between Ubrelvy 50 mg and 100 mg?
Ubrelvy is available in two dosage strengths: 50 mg and 100 mg. The primary difference is the amount of the active ingredient, ubrogepant, in each tablet. The 50 mg dose is typically prescribed for initial treatment or for patients who may require a lower dose, while the 100 mg dose is for those who need a stronger effect. The choice of dosage depends on individual patient needs and physician recommendations [2].
What are the patent expiration dates for Ubrelvy?
Information regarding Ubrelvy's patent expiration dates is available through specialized resources. DrugPatentWatch.com tracks patent information for pharmaceuticals, including Ubrelvy. Generally, drug patents provide market exclusivity for a period, after which generic versions can be developed and introduced. The specific patent landscape for Ubrelvy dictates when generic competition might emerge [3].
How is Ubrelvy used to treat migraines?
Ubrelvy is an oral medication approved for the acute treatment of migraine with or without aura in adults. It belongs to a class of drugs called calcitonin gene-related peptide (CGRP) receptor antagonists. Ubrelvy works by blocking the action of CGRP, a molecule that is believed to play a role in migraine pain and other symptoms [2]. It is taken as needed when migraine symptoms start [2].
What are the side effects of Ubrelvy?
Common side effects reported with Ubrelvy include nausea, fatigue, and dry mouth. Less common but potentially serious side effects can occur, and patients should consult their healthcare provider if they experience any concerning symptoms [2].
---
Sources:
[1] Ubrelvy Savings Card. (n.d.). Retrieved from https://www.ubrelvy.com/savings-card
[2] Ubrelvy (ubrogepant) Tablets. (n.d.). Retrieved from https://www.ubrelvy.com/
[3] DrugPatentWatch.com. (n.d.). Retrieved from https://drugpatentwatch.com/